PharmaMar (Spain)
In research, PharmaMar (Spain) stands highest in Biochemistry, Genetics and Molecular Biology (#4,389 of 5,801 worldwide), Life Sciences (#8,883 of 11,023 worldwide) and Health Sciences (#15,778 of 16,688 worldwide), over all time.
- World rank, all time
- #32,946 of 34,923
- Rank in Spain
- #627 of 646
- Research works
- 337 ▲ 14% vs 2018-21
- Citations
- 8.9k 26.3 per fractional work
- Top-10% rate
- 4.7% all institutions 10.0%
- vs its own fields
- 0.85× 1.00× is exactly expected
- Open access
- 30% world 40%
- International
- 36% world 18%
What is PharmaMar (Spain) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular BiologyField | #4,389 of 5,801 | 12.3% | 135 | |
| Life SciencesDomain | #8,883 of 11,023 | 11.7% | 156 | |
| Health SciencesDomain | #15,778 of 16,688 | 10.6% | 130 | |
| MedicineField | #14,080 of 14,558 | 10.7% | 128 |
Each strip is that field's whole ranked pool, with the notch where PharmaMar (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does PharmaMar (Spain) work in?
In 2022-now, 55% of research at PharmaMar (Spain) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (26%), Chemistry (7%). It does 2.0× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 19 fields, with their numbers
- Health Sciences2354.7%
- Medicine2354.3%
- Nursing00.3%
- Veterinary00.1%
- Life Sciences1332.0%
- Physical Sciences511.4%
- Chemistry37.0%
- Engineering11.5%
- Computer Science00.8%
- Mathematics00.8%
- Environmental Science00.4%
- Materials Science00.4%
- Physics and Astronomy00.3%
- Earth and Planetary Sciences00.2%
- Energy00.1%
- Social Sciences11.9%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.8×. Every wedge is a field page.
All 19 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology4.81×11 works
- Chemistry4.43×3 works
- Pharmacology, Toxicology and Pharmaceutics3.63×0 works
- Immunology and Microbiology3.44×1 works
- Medicine2.82×23 works
- Veterinary0.98×0 works
- Mathematics0.68×0 works
- Nursing0.55×0 works
- Economics, Econometrics and Finance0.50×0 works
- Agricultural and Biological Sciences0.33×1 works
- Psychology0.26×0 works
- Earth and Planetary Sciences0.13×0 works
- Physics and Astronomy0.12×0 works
- Materials Science0.11×0 works
- Computer Science0.10×0 works
- Energy0.10×0 works
- Engineering0.10×1 works
- Environmental Science0.09×0 works
- Neuroscience0.05×0 works
- Biochemistry, Genetics and Molecular Biology 4.8×
- Chemistry 4.4×
- Pharmacology, Toxicology and Pharmaceutics 3.6×
- Immunology and Microbiology 3.4×
- Medicine 2.8×
- Veterinary 1.0×
- Mathematics 0.7×
- Nursing 0.6×
- Economics, Econometrics and Finance 0.5×
- Agricultural and Biological Sciences 0.3×
- Psychology 0.3×
- Earth and Planetary Sciences 0.1×
- Physics and Astronomy 0.1×
- Materials Science 0.1×
- Computer Science 0.1×
- Energy 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
- Neuroscience 0.1×
Who are the top researchers at PharmaMar (Spain)?
Ranked on the quality score, José María Jimeno, Ali Hassan Zeaiter and Gema Santamaría Núñez lead among researchers whose main affiliation is PharmaMar (Spain).
- 1
José María Jimeno
Spain · #619,946 worldwide 9.3k citations · 201 works
- 2
Ali Hassan Zeaiter
Spain · #709,709 worldwide 6.5k citations · 98 works
- 3
Gema Santamaría Núñez
Spain · #1,143,624 worldwide 616 citations · 40 works
- 4
Juan Fernando Martínez-Leal
Spain · #1,440,872 worldwide 5.4k citations · 119 works
- 5
Alejandro Losada
Spain · #1,456,560 worldwide 1.2k citations · 44 works
- 6
Juan Carlos Tercero
Spain · #1,601,518 worldwide 2.3k citations · 91 works
- 7
Carmen Maria Kahatt
Spain · #1,624,371 worldwide 3.3k citations · 138 works
- 8
Carlos María Galmarini
Spain · #1,637,534 worldwide 10k citations · 317 works
- 9
Pablo Avilés
Spain · #1,642,842 worldwide 1.9k citations · 167 works
- 10
Marta Martínez
Spain · #2,050,425 worldwide 1.5k citations · 60 works
Which keywords describe research at PharmaMar (Spain)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Immunotherapy, Targeted Therapy, Biomarkers, Prognostic Factors, Metastasis and Marine Natural Products.
- Pancreatic Neuroendocrine Tumors
- Cell Death
- Transcriptional Regulation
- Survival Analysis
- Anticancer Agents
- Precision Medicine
- Tumor Targeting
- Topoisomerases
- Hematological Malignancies
- ALK Inhibitors
- Inflammation
- Cancer
- Natural Products
- Antibiotics
- Small-Cell Lung Cancer
- Drug Discovery
- Marine Natural Products
- Metastasis
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- Immunotherapy
- Biomarkers
- Prognostic Factors
- Cancer Therapy
- Genomic Profiles
- Secondary Metabolites
- Genome Sequencing
- Pharmacology
- Genomic Profiling
- Genetic Mutations
- EGFR Mutations
- DNA
- Tumor Microenvironment
- Microbial Symbionts
- Sponge-Associated Microorganisms
- PET Imaging
- Total Synthesis
- Tumor Regression
- Neuroendocrine Tumors
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy7▲ 23×10 topics
- Clinical Trials6▲ 21×7 topics
- Immunotherapy5▲ 18×8 topics
- Targeted Therapy5▲ 52×4 topics
- Biomarkers5▲ 16×11 topics
- Metastasis4▲ 27×4 topics
- Prognostic Factors4▲ 21×5 topics
- Marine Natural Products4▲ 207×2 topics
- Cancer Therapy3▲ 14×9 topics
- Drug Discovery3▲ 36×3 topics
- Genomic Profiles3▲ 158×1 topic
- Small-Cell Lung Cancer3▲ 158×1 topic
- Secondary Metabolites3▲ 86×2 topics
- Antibiotics3▲ 74×1 topic
- Genome Sequencing3▲ 40×2 topics
- Natural Products3▲ 43×1 topic
- Pharmacology3▲ 26×5 topics
- Cancer2▲ 4.0×15 topics
- Genomic Profiling2▲ 52×2 topics
- Inflammation2▲ 2.4×15 topics
- Genetic Mutations2▲ 10×5 topics
- ALK Inhibitors2▲ 68×1 topic
- EGFR Mutations2▲ 68×1 topic
- Hematological Malignancies2▲ 104×2 topics
- DNA1▲ 200×1 topic
- Topoisomerases1▲ 200×1 topic
- Tumor Microenvironment1▲ 7.6×6 topics
- Tumor Targeting1▲ 18×3 topics
- Microbial Symbionts1▲ 199×1 topic
- Precision Medicine1▲ 5.7×5 topics
- Sponge-Associated Microorganisms1▲ 199×1 topic
- Anticancer Agents1▲ 18×4 topics
- PET Imaging1▲ 15×4 topics
- Survival Analysis1▲ 9.3×2 topics
- Total Synthesis1▲ 79×2 topics
- Transcriptional Regulation1▲ 15×2 topics
- Tumor Regression1▲ 24×2 topics
- Cell Death1▲ 10×2 topics
- Neuroendocrine Tumors1▲ 77×1 topic
- Pancreatic Neuroendocrine Tumors1▲ 77×1 topic
Which research topics does PharmaMar (Spain) publish most on?
By volume in 2022-now: Lung Cancer Research Studies, Microbial Natural Products and Biosynthesis, Lung Cancer Treatments and Mutations and Cancer therapeutics and mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Research Studies Oncology 3 works
- 2 Microbial Natural Products and Biosynthesis Pharmacology 3 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 4 Cancer therapeutics and mechanisms Molecular Biology 1 works
- 5 Marine Sponges and Natural Products Biotechnology 1 works
- 6 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 1 works
- 7 Neuroendocrine Tumor Research Advances Epidemiology 1 works
- 8 Protein Degradation and Inhibitors Molecular Biology 1 works
- 9 PARP inhibition in cancer therapy Oncology 1 works
- 10 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has PharmaMar (Spain)'s research output changed?
Output in 2022-2025 was 14% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is PharmaMar (Spain) as a percentage of every work published that year, 0.00015% in 2024.
Fractional works of PharmaMar (Spain) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Instituto de Salud Carlos III
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about PharmaMar (Spain). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
